MCT4 is a therapeutic target for inflammatory arthritis
Read Publication
http://dx.doi.org/10.1002/art.39270
The following have contributed to this page: Dr Wataru Fujii
In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Monocarboxylate Transporter 4, Associated With the Acidification of Synovial Fluid, Is a Novel Therapeutic Target for Inflammatory Arthritis
- MCT4 IS A THERAPEUTIC TARGET FOR INFLAMMATORY ARTHRITIS
- Wataru Fujii, Yutaka Kawahito, Hidetake Nagahara, Yuji Kukida, Takahiro Seno, Aihiro Yamamoto, Masataka Kohno, Ryo Oda, Daigo Taniguchi, Hiroyoshi Fujiwara, Akika Ejima, Tsunao Kishida, Osam Mazda, Eishi Ashihara
- Arthritis & Rheumatology, October 2015, Wiley
- DOI: 10.1002/art.39270